1 option
RNA-based vaccines for cancer / Duane A. Mitchell.
- Format:
- Video
- Author/Creator:
- Mitchell, Duane A., 1971- Speaker.
- Series:
- Henry Stewart talks. Biomedical & life sciences collection.
- The biomedical & life sciences collection, 2056-452X
- Language:
- English
- Subjects (All):
- Cancer--Immunotherapy.
- Cancer.
- Cancer--Vaccination.
- Drug targeting.
- Nanomedicine.
- Pharmaceutical biotechnology.
- RNA--Biotechnology.
- RNA.
- Vaccines.
- Antigen-Presenting Cells.
- Brain Neoplasms--immunology.
- Brain Neoplasms--therapy.
- Cancer Vaccines.
- Clinical Trials as Topic.
- Drug Delivery Systems--methods.
- Immunotherapy.
- Nanoparticles.
- Neoplasms--immunology.
- Neoplasms--therapy.
- RNA, Messenger--administration & dosage.
- Vaccines, Synthetic--therapeutic use.
- Medical Subjects:
- Antigen-Presenting Cells.
- Brain Neoplasms--immunology.
- Brain Neoplasms--therapy.
- Cancer Vaccines.
- Clinical Trials as Topic.
- Drug Delivery Systems--methods.
- Immunotherapy.
- Nanoparticles.
- Neoplasms--immunology.
- Neoplasms--therapy.
- RNA, Messenger--administration & dosage.
- Vaccines, Synthetic--therapeutic use.
- Physical Description:
- 1 online resource (1 streaming video file (65 min.)) : sound, color
- Place of Publication:
- London : Henry Stewart Talks, 2023.
- System Details:
- video file
- Summary:
- Vaccination strategies for the treatment of a variety of cancers have long been explored for inducing antitumor immunity. Cancer immunotherapeutic vaccines utilizing mRNA, drive antigen expression by antigen presenting cells, triggering an antigen-specific immune response. In this webinar, Prof. Duane A. Mitchell, MD, PhD (University of Florida) will provide an overview of RNA-based vaccines used for the treatment of a variety of cancer types, including brain tumors. The discussion will focus on the use of cellular-based platforms as well as the use of nanoparticles as vehicles for RNA delivery. The talk will explore their efficacy in preclinical and clinical studies and compare the advantages and disadvantages of RNA-based vaccines for their use in the treatment of cancer..
- Notes:
- Description based on publisher supplied metadata and other sources.
- Title from title frames.
- Webinar.
- Publisher Number:
- 11009 Henry Stewart Talks
The Penn Libraries is committed to describing library materials using current, accurate, and responsible language. If you discover outdated or inaccurate language, please fill out this feedback form to report it and suggest alternative language.